Morgan Stanley’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$23M Sell
202,409
-36,683
-15% -$4.17M ﹤0.01% 2662
2025
Q1
$25.1M Buy
239,092
+31,230
+15% +$3.28M ﹤0.01% 2459
2024
Q4
$22.3M Sell
207,862
-29,151
-12% -$3.12M ﹤0.01% 2644
2024
Q3
$23.7M Buy
237,013
+42,675
+22% +$4.27M ﹤0.01% 2632
2024
Q2
$16.4M Sell
194,338
-57,559
-23% -$4.85M ﹤0.01% 2879
2024
Q1
$18.4M Sell
251,897
-146,491
-37% -$10.7M ﹤0.01% 2786
2023
Q4
$28.5M Buy
398,388
+203,381
+104% +$14.5M ﹤0.01% 3020
2023
Q3
$11.7M Buy
195,007
+26,741
+16% +$1.6M ﹤0.01% 2981
2023
Q2
$12.1M Buy
168,266
+13,187
+9% +$951K ﹤0.01% 2983
2023
Q1
$11.4M Sell
155,079
-29,491
-16% -$2.17M ﹤0.01% 3028
2022
Q4
$12.3M Sell
184,570
-8,534
-4% -$570K ﹤0.01% 2866
2022
Q3
$10.4M Sell
193,104
-44,478
-19% -$2.39M ﹤0.01% 2940
2022
Q2
$13.2M Buy
237,582
+9,045
+4% +$503K ﹤0.01% 2756
2022
Q1
$16M Buy
228,537
+103,610
+83% +$7.27M ﹤0.01% 2362
2021
Q4
$12M Sell
124,927
-28,259
-18% -$2.72M ﹤0.01% 2739
2021
Q3
$13.3M Buy
153,186
+10,101
+7% +$878K ﹤0.01% 2566
2021
Q2
$11.7M Buy
143,085
+38,590
+37% +$3.16M ﹤0.01% 2802
2021
Q1
$9.94M Buy
104,495
+29,997
+40% +$2.85M ﹤0.01% 2659
2020
Q4
$4.62M Sell
74,498
-87,913
-54% -$5.45M ﹤0.01% 3340
2020
Q3
$9.66M Buy
162,411
+77,691
+92% +$4.62M ﹤0.01% 2061
2020
Q2
$5.91M Buy
84,720
+54,513
+180% +$3.8M ﹤0.01% 2500
2020
Q1
$1.37M Sell
30,207
-162,820
-84% -$7.39M ﹤0.01% 3693
2019
Q4
$12.6M Buy
193,027
+129,313
+203% +$8.41M ﹤0.01% 2147
2019
Q3
$3.96M Buy
63,714
+10,736
+20% +$667K ﹤0.01% 3124
2019
Q2
$3.77M Buy
52,978
+35,691
+206% +$2.54M ﹤0.01% 3218
2019
Q1
$1.36M Sell
17,287
-183,801
-91% -$14.4M ﹤0.01% 3896
2018
Q4
$17M Buy
201,088
+7,300
+4% +$618K 0.01% 1605
2018
Q3
$33.2M Sell
193,788
-18,880
-9% -$3.23M 0.01% 1247
2018
Q2
$27.5M Buy
212,668
+77,667
+58% +$10M 0.01% 1345
2018
Q1
$13.9M Sell
135,001
-54,179
-29% -$5.58M ﹤0.01% 2021
2017
Q4
$16.2M Buy
189,180
+29,736
+19% +$2.54M ﹤0.01% 1899
2017
Q3
$13.5M Buy
159,444
+111,275
+231% +$9.45M ﹤0.01% 1973
2017
Q2
$3.65M Sell
48,169
-10,116
-17% -$766K ﹤0.01% 3216
2017
Q1
$3.85M Sell
58,285
-77,686
-57% -$5.13M ﹤0.01% 3140
2016
Q4
$8.62M Buy
135,971
+74,666
+122% +$4.73M ﹤0.01% 2419
2016
Q3
$3.9M Sell
61,305
-147,587
-71% -$9.4M ﹤0.01% 2914
2016
Q2
$15.5M Buy
208,892
+1,717
+0.8% +$128K 0.01% 1625
2016
Q1
$13.8M Buy
207,175
+70,527
+52% +$4.71M 0.01% 1607
2015
Q4
$9.24M Buy
136,648
+108,551
+386% +$7.34M ﹤0.01% 2059
2015
Q3
$1.5M Sell
28,097
-90,254
-76% -$4.82M ﹤0.01% 3769
2015
Q2
$7.45M Buy
118,351
+105,263
+804% +$6.63M ﹤0.01% 2404
2015
Q1
$630K Sell
13,088
-5,029
-28% -$242K ﹤0.01% 4490
2014
Q4
$601K Sell
18,117
-8,068
-31% -$268K ﹤0.01% 4530
2014
Q3
$767K Sell
26,185
-7,855
-23% -$230K ﹤0.01% 4267
2014
Q2
$1.32M Sell
34,040
-20,749
-38% -$806K ﹤0.01% 3822
2014
Q1
$2.3M Sell
54,789
-30,050
-35% -$1.26M ﹤0.01% 3299
2013
Q4
$2.78M Buy
84,839
+18,949
+29% +$622K ﹤0.01% 3119
2013
Q3
$1.78M Sell
65,890
-17,068
-21% -$461K ﹤0.01% 3327
2013
Q2
$1.94M Buy
+82,958
New +$1.94M ﹤0.01% 3178